MedAdvisor (ASX:MDR) has completed a strategic review after the successful acquisition and integration of GuildLink, identifying significant cost-saving measures and streamlining operations.

The company said this includes a 20% reduction in the Australian workforce, which will save an estimated $2M annually starting from FY24.

MedAdvisor also said it expects revenue of $95-$97M in FY23, a 40%-43% increase from the previous year, and a significant improvement in EBITDA, ranging from ($3.5) million to ($3) million.

It added that it's now positioned for profitability in FY24 and aims to capitalise on its growing US pipeline during the Q1 and Q2 FY24 selling periods.